Gubra AS (HAM:PI3) NonCurrent Deferred Revenue: €0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HAM:PI3 Gubra AS HAM:PI3
49 GF Score
Price €49.70
GF Value €26.64
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Gubra AS NonCurrent Deferred Revenue?

Gubra AS HAM:PI3 +1.14% 49 NonCurrent Deferred Revenue is €0.00 Mil as of Jun. 2026. GuruFocus rates HAM:PI3 with a GF Score™ of 49/100 and a GF Value™ of €26.64 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Non-Current Deferred Revenue represents the non-current portion of deferred revenue amount as of the balance sheet date. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months.

Gubra AS's non-current deferred revenue for the quarter that ended in Jun. 2026 was €0.00 Mil.

Gubra AS NonCurrent Deferred Revenue Related Terms

Gubra AS NonCurrent Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Gubra AS's NonCurrent Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gubra AS NonCurrent Deferred Revenue Chart

Gubra AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
NonCurrent Deferred Revenue
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Gubra AS Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
NonCurrent Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HAM:PI3
49GF Score
Gubra AS HAM:PI3
NonCurrent Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Revenue of €0.00 Mil mean?
Gubra AS (HAM:PI3) has a NonCurrent Deferred Revenue of €0.00 Mil as of Jun. 2026. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months. View historical data on Gubra AS and its competitors.
Is Gubra AS's NonCurrent Deferred Revenue too high?
Gubra AS's current NonCurrent Deferred Revenue is €0.00 Mil. Overall, Gubra AS has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Gubra AS's NonCurrent Deferred Revenue compare to VRTX and REGN?
Gubra AS's NonCurrent Deferred Revenue of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Revenue for a Biotechnology company?
A good NonCurrent Deferred Revenue depends on the Biotechnology industry context. However, NonCurrent Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Revenue mean?
A high NonCurrent Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months. View historical data on Gubra AS and its competitors. Gubra AS's current NonCurrent Deferred Revenue is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gubra AS stock overvalued right now?
Based on GuruFocus' analysis, Gubra AS (HAM:PI3) is currently considered Significantly Overvalued. The stock's GF Value™ is €26.64, compared to a current price of €49.70 — trading 86.6% above its estimated fair value. The current NonCurrent Deferred Revenue is €0.00 Mil. Gubra AS's overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Revenue calculated?
NonCurrent Deferred Revenue is calculated from a company's financial statements. For Gubra AS (HAM:PI3), the current NonCurrent Deferred Revenue is €0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gubra AS (HAM:PI3) Overvalued in 2026?

Based on GuruFocus' analysis, Gubra AS stock appears to be overvalued. The current stock price of €49.70 is trading 86.6% above its estimated GF Value™ of €26.64. GuruFocus considers Gubra AS to be Significantly Overvalued.

Key valuation signals for HAM:PI3:

  • NonCurrent Deferred Revenue: €0.00 Mil
  • GF Value™: €26.64 vs. price of €49.70 (86.6% above fair value)
  • GF Score™: 49/100 with 4 warning signs

No single metric tells the full story. See the HAM:PI3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gubra AS Business Description

Other Exchanges GUBRA:DenmarkPI3:Germany
Address Horsholm Kongevej 11B, Horsholm, DNK, 2970
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases. The company has two segments: Pre-clinical contract research (CRO), which derives maximum revenue and Biotech Segment. It derives maximum revenue from Pre-clinical contract research (CRO) segment. Geographically, the company operates in Europe, North America and Other regions.
49GF Score

Get the complete analysis for HAM:PI3

NonCurrent Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€49.70
Price
€26.64
GF Value